Jefferies Raises Estimates on Akamai Technologies (AKAM); Early in Several Product Cycles
Get Alerts AKAM Hot Sheet
Price: $124.99 -0.24%
Rating Summary:
18 Buy, 20 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
18 Buy, 20 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies maintains a 'Buy' on Akamai Technologies (NASDAQ: AKAM) price target of $43.00 (from $42.00).
Analyst, Aaron Schwartz, said, "AKAM reported 2Q upside with guidance above consensus as strong business trends offset currency adjustment concerns. The company is early in several product cycles with additional releases expected in 2H with a backdrop of strong volume traffic trends. Estimates move higher and further stock appreciation potential exists based just on in line historic valuation levels."
FY12 EPS estimate raised from $1.64 to $1.74 and FY13 $1.87 to $1.95.
For an analyst ratings summary and ratings history on Akamai Technologies click here. For more ratings news on Akamai Technologies click here.
Shares of Akamai Technologies closed at $28.25 yesterday.
Analyst, Aaron Schwartz, said, "AKAM reported 2Q upside with guidance above consensus as strong business trends offset currency adjustment concerns. The company is early in several product cycles with additional releases expected in 2H with a backdrop of strong volume traffic trends. Estimates move higher and further stock appreciation potential exists based just on in line historic valuation levels."
FY12 EPS estimate raised from $1.64 to $1.74 and FY13 $1.87 to $1.95.
For an analyst ratings summary and ratings history on Akamai Technologies click here. For more ratings news on Akamai Technologies click here.
Shares of Akamai Technologies closed at $28.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Akamai Technologies (AKAM) to Neutral 'on Account of Confidence in Revenue Reacceleration'
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share